Met-Rx Substrate Technology, Inc. Sustainability Profile
Met-Rx Substrate Technology, Inc., headquartered in the United States, is a leading innovator in the nutritional supplement industry. Founded in the early 1990s, the company has established itself as a pioneer in formulating high-quality protein products and performance-enhancing supplements. With a focus on research and development, Met-Rx has introduced unique offerings such as their proprietary protein blends and advanced meal replacement solutions. The company operates primarily in North America, catering to fitness enthusiasts and athletes seeking optimal nutrition. Met-Rx's commitment to quality and efficacy has earned it a strong market position, recognised for its scientifically-backed formulations. Notable achievements include numerous industry awards and a loyal customer base that values the brand's dedication to performance and health.
DitchCarbon Score
How does Met-Rx Substrate Technology, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Food Product Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Met-Rx Substrate Technology, Inc.'s score of 15 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Met-Rx Substrate Technology, Inc.'s reported carbon emissions
Met-Rx Substrate Technology, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of The Bountiful Company, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from Met-Rx Substrate Technology, Inc., it is important to note that emissions data and sustainability initiatives may be inherited from its parent company. The Bountiful Company, as the source organization, may have its own climate strategies and targets that could impact Met-Rx's environmental performance. As of now, Met-Rx Substrate Technology, Inc. has not established specific science-based targets or commitments to reduce emissions, which places it in a broader context of industry practices where many companies are increasingly focusing on sustainability and carbon neutrality. The absence of specific data highlights the need for enhanced transparency and commitment to climate action within the organisation.
How Carbon Intensive is Met-Rx Substrate Technology, Inc.'s Industry?
How Carbon Intensive is Met-Rx Substrate Technology, Inc.'s Location?
Met-Rx Substrate Technology, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Met-Rx Substrate Technology, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
